Financements par thème

Drug development, clinical phases : subventions et appels à propositions

4 appels en cours étiquetés « Drug development, clinical phases » par leurs bailleurs.

Clôture dans les 14 prochains joursVérifiez votre éligibilité

4 appels en cours · triés par date de clôture

À venirEU Funding & Tenders portal

Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential

European Commission · Horizon Europe Framework Programme (HORIZON)

Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals…

  • Andes
  • Enterovirus
  • GMP
  • Hantaan
  • Hendra

17 févr. 2027

Environ 4 mois restants

3 000 000 € – 11 M € par subvention

À venirEU Funding & Tenders portal

Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

European Commission · Horizon Europe Framework Programme (HORIZON)

Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals…

  • Dengue
  • GMP
  • West Nile
  • Yellow Fever
  • Zika

17 févr. 2027

Environ 4 mois restants

3 000 000 € – 11 M € par subvention

À venirEU Funding & Tenders portal

Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses

European Commission · Horizon Europe Framework Programme (HORIZON)

Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals…

  • Chikungunya
  • Congo
  • Crimean
  • Ebola
  • Enterovirus

17 févr. 2027

Environ 4 mois restants

3 000 000 € – 11 M € par subvention

À venirEU Funding & Tenders portal

European Partnership for Pandemic Preparedness (Phase 2)

European Commission · Horizon Europe Framework Programme (HORIZON)

Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. Proposals under this topic…

  • Basic medicine
  • Clinical Pharmacology
  • Clinical research
  • Clinical trials
  • Cohort studies

13 avr. 2027

Environ 6 mois restants

63 M € – 63 M € par subvention